Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-14-377632
Filing Date
2014-10-21
Accepted
2014-10-21 17:27:14
Documents
4
Effectiveness Date
2014-10-21

Document Format Files

Seq Description Document Type Size
1 S-8 d807728ds8.htm S-8 85490
2 EX-5.1 d807728dex51.htm EX-5.1 7035
3 EX-23.2 d807728dex232.htm EX-23.2 1857
4 GRAPHIC g807728img1.jpg GRAPHIC 7046
  Complete submission text file 0001193125-14-377632.txt   105231
Mailing Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005 415-287-2410
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-199508 | Film No.: 141166388
SIC: 2836 Biological Products, (No Diagnostic Substances)